The treatment of arterial hypertension with a new alpha-blocker, indoramin.
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000428:Alcohol Drinking; D000704:Analysis of Variance; D001794:Blood Pressure; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos; D012907:Smoking; D013610:Tachycardia / Q000139:chemically induced; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D007211:Indoles; D010880:Piperidines; D010919:Placebos